Goldman Sachs
AMPE

Goldman Sachs’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Goldman Sachs’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24
Closed -$4K – 5815
2018
Q3 		$4K Buy
+24
New +$10K ﹤0.01% 5525
2015
Q2 		– Sell
-53
Closed -$120K – 7505
2015
Q1 		$120K Buy
+53
New +$90.4K ﹤0.01% 6348
2013
Q4 		– Sell
-92
Closed -$207K – 6845
2013
Q3 		$207K Buy
+92
New +$178K ﹤0.01% 5847

Other funds holding AMPE

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Goldman Sachs's AMPE Position: Q2 2023 in Review

Goldman Sachs sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 646 shares — an estimated $3.01K sold.

Goldman Sachs first reported a position in AMPE in Q2 2013 and held it in 28 quarters. The position peaked at $950K in Q1 2018. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

  • Goldman Sachs reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 646 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $3.01K.
  • Goldman Sachs first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 28 quarters.
  • Goldman Sachs's Ampio Pharmaceuticals Inc. position peaked at $950K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.